Ranolazine Therapy

Ranolazine Therapy is a pharmacological treatment method that selectively inhibits the late sodium current in cardiac myocytes to reduce myocardial ischemia and improve exercise tolerance in chronic angina patients unresponsive to conventional antianginal therapies.

268

Publications

16.9K

Citations

1.5K

Authors

458

Institutions

Publications per year

2017–2026

55

Authors

1.5K

  1. LB
    Luiz Belardinelli

    Gilead Sciences (United States), United States

    63 publications · 5.5K citations

    39

    h-index

  2. DA
    David A. Morrow

    Brigham and Women's Hospital, United States

    16 publications · 1.5K citations

    15

    h-index

  3. SR
    Sridharan Rajamani

    Gilead Sciences (United States), United States

    15 publications · 566 citations

    14

    h-index

  4. BM
    Benjamin M. Scirica

    Brigham and Women's Hospital, United States

    13 publications · 896 citations

    13

    h-index

  5. AK
    Arvinder K. Dhalla

    Gilead Sciences (United States), United States

    12 publications · 568 citations

    12

    h-index

1–5 of 1.5K

Venues

  1. Journal of the American College of Cardiology

    JACC · 12 publications · 1.9K citations

    12

    h-index

  2. Heart Rhythm

    11 publications · 565 citations

    11

    h-index

  3. The American Journal of Cardiology

    11 publications · 803 citations

    10

    h-index

  4. 9

    h-index

  5. Journal of Cardiovascular Pharmacology

    9 publications · 529 citations

    9

    h-index

1–5